Immune Prophets of Lung Cancer: The Prognostic and Predictive Landscape of Cellular and Molecular Immune Markers
Lung cancer is the leading cause of cancer deaths throughout the world. The majority of patients are diagnosed with locally advanced or metastatic disease when surgery, the best curative option, is no longer feasible. Thus, the prognosis of lung cancer remains poor and heterogeneous and new biomarke...
Main Authors: | Ivana Catacchio, Anna Scattone, Nicola Silvestris, Anita Mangia |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2018-06-01
|
Series: | Translational Oncology |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1936523318300949 |
Similar Items
-
Intratumoral, rather than stromal, CD8+ T cells could be a potential negative prognostic marker in invasive breast cancer patients
by: Ivana Catacchio, et al.
Published: (2019-03-01) -
Immune cell infiltration landscape and immune marker molecular typing in preeclampsia
by: YiLin Meng, et al.
Published: (2021-01-01) -
Immune landscape and a promising immune prognostic model associated with TP53 in early‐stage lung adenocarcinoma
by: Chengde Wu, et al.
Published: (2021-02-01) -
Immune cell landscape analysis reveals prognostic immune cells and its potential mechanism in squamous cell lung carcinoma
by: Yongyong Wang, et al.
Published: (2020-10-01) -
Recognition of Immune Microenvironment Landscape and Immune-Related Prognostic Genes in Breast Cancer
by: Huiling Wang, et al.
Published: (2020-01-01)